Central Trust Company’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$520K Buy
4,400
+46
+1% +$5.31K 0.01% 461
2026
Q1
$520K Sell
4,354
-287
-6% -$37.6K 0.01% 433
2025
Q4
$632K Sell
4,641
-21
-0.5% -$3.02K 0.01% 398
2025
Q3
$688K Buy
4,662
+6
+0.1% +$832 0.01% 384
2025
Q2
$602K Sell
4,656
-185
-4% -$22.4K 0.01% 386
2025
Q1
$578K Sell
4,841
-159
-3% -$19.7K 0.01% 391
2024
Q4
$580K Buy
5,000
+18
+0.4% +$2.28K 0.01% 388
2024
Q3
$673K Sell
4,982
-83
-2% -$11.1K 0.02% 375
2024
Q2
$687K Buy
5,065
+41
+0.8% +$5.58K 0.02% 366
2024
Q1
$649K Buy
5,024
+10
+0.2% +$1.21K 0.02% 385
2023
Q4
$573K Sell
5,014
-9
-0.2% -$898 0.02% 394
2023
Q3
$457K Buy
5,023
+770
+18% +$79.4K 0.01% 419
2023
Q2
$479K Sell
4,253
-12
-0.3% -$1.27K 0.01% 418
2023
Q1
$447K Buy
4,265
+41
+1% +$4.28K 0.01% 425
2022
Q4
$467K Buy
4,224
+204
+5% +$21.4K 0.01% 404
2022
Q3
$352K Sell
4,020
-205
-5% -$18.6K 0.01% 429
2022
Q2
$330K Sell
4,225
-697
-14% -$57.5K 0.01% 441
2022
Q1
$420K Sell
4,922
-2,960
-38% -$284K 0.01% 443
2021
Q4
$945K Buy
7,882
+138
+2% +$17.1K 0.03% 338
2021
Q3
$958K Sell
7,744
-9,417
-55% -$1.21M 0.03% 321
2021
Q2
$2.06M Buy
17,161
+5,596
+48% +$639K 0.07% 217
2021
Q1
$1.22M Buy
11,565
+3,503
+43% +$355K 0.05% 264
2020
Q4
$821K Buy
8,062
+4,526
+128% +$425K 0.03% 301
2020
Q3
$298K Buy
3,536
+514
+17% +$40K 0.01% 398
2020
Q2
$196K Buy
3,022
+1,032
+52% +$68.1K 0.01% 441
2020
Q1
$130K Sell
1,990
-981
-33% -$77.3K 0.01% 473
2019
Q4
$234K Buy
2,971
+281
+10% +$21.9K 0.01% 435
2019
Q3
$214K Sell
2,690
-468
-15% -$36.8K 0.01% 432
2019
Q2
$256K Buy
3,158
+892
+39% +$71.1K 0.01% 419
2019
Q1
$179K Sell
2,266
-100
-4% -$7.3K 0.01% 453
2018
Q4
$158K Buy
2,366
+40
+2% +$2.77K 0.01% 470
2018
Q3
$186K Buy
2,326
+879
+61% +$65.6K 0.01% 478
2018
Q2
$97K Sell
1,447
-1,315
-48% -$95.5K 0.01% 557
2018
Q1
$212K Sell
2,762
-511
-16% -$37.8K 0.01% 458
2017
Q4
$223K Sell
3,273
-70
-2% -$4.65K 0.01% 460
2017
Q3
$209K Buy
3,343
+688
+26% +$41.1K 0.01% 451
2017
Q2
$146K Buy
2,655
+1,635
+160% +$85.2K 0.01% 505
2017
Q1
$51K Buy
1,020
+155
+18% +$7.55K ﹤0.01% 713
2016
Q4
$43K Hold
865
﹤0.01% 740
2016
Q3
$45K Hold
865
﹤0.01% 703
2016
Q2
$39K Hold
865
﹤0.01% 738
2016
Q1
$35K Buy
865
+150
+21% +$5.52K ﹤0.01% 759
2015
Q4
$26K Hold
715
﹤0.01% 810
2015
Q3
$23K Sell
715
-75
-9% -$2.52K ﹤0.01% 801
2015
Q2
$29K Sell
790
-200
-20% -$7.28K ﹤0.01% 781
2015
Q1
$35K Hold
990
﹤0.01% 719
2014
Q4
$38K Hold
990
﹤0.01% 706
2014
Q3
$35K Sell
990
-50
-5% -$1.86K ﹤0.01% 730
2014
Q2
$41K Sell
1,040
-50
-5% -$1.87K ﹤0.01% 710
2014
Q1
$40K Sell
1,090
-50
-4% -$1.82K ﹤0.01% 714
2013
Q4
$39K Hold
1,140
﹤0.01% 723
2013
Q3
$32K Sell
1,140
-125
-10% -$3.33K ﹤0.01% 747
2013
Q2
$34K Buy
+1,265
New +$34.9K ﹤0.01% 695

Other funds holding XYL

Central Trust Company's XYL Position: Q2 2026 in Review

Central Trust Company increased its Xylem (XYL) stake by 1.1% in Q2 2026, buying an estimated $5.31K and bringing the position to 4,400 shares worth $520K. The position accounts for 0.01% of the portfolio, ranked #461.

Central Trust Company first reported a position in XYL in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.06M in Q2 2021. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Central Trust Company held 4,400 shares of Xylem worth $520K as of Q2 2026.
  • Central Trust Company bought 46 Xylem shares in Q2 2026, an estimated $5.31K.
  • Xylem made up 0.01% of Central Trust Company's portfolio in Q2 2026, its #461 holding.
  • Central Trust Company first reported a position in Xylem in Q2 2013 and has held it in 53 quarters since.
  • Central Trust Company's Xylem position peaked at $2.06M in Q2 2021.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.